Nepean, Canada

Wangxue Chen

USPTO Granted Patents = 8 

 

 

Average Co-Inventor Count = 3.1

ph-index = 3

Forward Citations = 37(Granted Patents)


Location History:

  • Nepean, CA (2014 - 2019)
  • Ottawa, CA (2019 - 2023)

Company Filing History:


Years Active: 2014-2025

Loading Chart...
Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: Innovations of Wangxue Chen

Introduction

Wangxue Chen is a notable inventor based in Nepean, Canada. He has made significant contributions to the field of immunology, holding a total of 8 patents. His work focuses on developing innovative methods to induce immune responses using engineered live vectors.

Latest Patents

Wangxue Chen's latest patents include "Livetyphi vectors engineered to express heterologous outer membrane protein antigens and methods of use thereof." This invention provides compositions and methods for inducing an immune response in subjects by administering an immunologically-effective amount of a live vector containing a heterologous antigen from a pathogen. The antigen is delivered to mucosal tissues via outer membrane vesicles. Another significant patent is "Livevectors engineered to express heterologous outer membrane protein antigens and methods of use thereof," which shares similar methodologies and applications in immune response induction.

Career Highlights

Throughout his career, Wangxue Chen has worked with esteemed institutions such as the National Research Council of Canada and Brock University. His research has contributed to advancements in vaccine development and immunotherapy.

Collaborations

Wangxue Chen has collaborated with notable colleagues, including Hongbin Yan and Rhonda Kuo Lee, enhancing the impact of his research through teamwork and shared expertise.

Conclusion

Wangxue Chen's innovative work in the field of immunology and his numerous patents highlight his significant contributions to science and medicine. His dedication to advancing immune response technologies continues to influence the field positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…